Yeah, we will be at that target, probably 2nd quarter, sometime. This company is very shrewd. You should here all the details in today's presentation. Nothing to chance, setting nice price for Uceris, multiple indications for Rif, Ruconest etc. possible. Biologics with small molecules, We are going higher. I have been doing this for a long time. Patience!!